This company listing is no longer active
Lotus Ventures 過去の業績
過去 基準チェック /06
Lotus Ventures's earnings have been declining at an average annual rate of -19.3%, while the Pharmaceuticals industry saw earnings growing at 67.6% annually. Revenues have been growing at an average rate of 20.7% per year.
主要情報
-19.3%
収益成長率
-7.3%
EPS成長率
| Pharmaceuticals 業界の成長 | 23.1% |
| 収益成長率 | 20.7% |
| 株主資本利益率 | -20.5% |
| ネット・マージン | -93.7% |
| 前回の決算情報 | 31 Aug 2023 |
収支内訳
Lotus Ventures の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Aug 23 | 2 | -2 | 1 | 0 |
| 31 May 23 | 2 | -6 | 1 | 0 |
| 28 Feb 23 | 2 | -6 | 1 | 0 |
| 30 Nov 22 | 1 | -6 | 1 | 0 |
| 31 Aug 22 | 2 | -5 | 1 | 0 |
| 31 May 22 | 2 | 0 | 1 | 0 |
| 28 Feb 22 | 3 | 0 | 1 | 0 |
| 30 Nov 21 | 5 | 1 | 1 | 0 |
| 31 Aug 21 | 5 | 0 | 2 | 0 |
| 31 May 21 | 6 | 0 | 2 | 0 |
| 28 Feb 21 | 6 | 1 | 2 | 0 |
| 30 Nov 20 | 6 | 0 | 2 | 0 |
| 31 Aug 20 | 5 | 1 | 1 | 0 |
| 31 May 20 | 3 | 1 | 1 | 0 |
| 29 Feb 20 | 1 | -1 | 2 | 0 |
| 30 Nov 19 | 0 | -1 | 2 | 0 |
| 31 Aug 19 | 0 | -3 | 3 | 0 |
| 31 May 19 | 0 | -2 | 2 | 0 |
| 28 Feb 19 | 0 | -3 | 3 | 0 |
| 30 Nov 18 | 0 | -3 | 3 | 0 |
| 31 Aug 18 | 0 | -3 | 2 | 0 |
| 31 May 18 | 0 | -2 | 2 | 0 |
| 28 Feb 18 | 0 | -2 | 2 | 0 |
| 30 Nov 17 | 0 | -1 | 1 | 0 |
| 31 Aug 17 | 0 | -1 | 1 | 0 |
| 31 May 17 | 0 | -1 | 1 | 0 |
| 28 Feb 17 | 0 | -1 | 1 | 0 |
| 30 Nov 16 | 0 | -1 | 1 | 0 |
| 31 Aug 16 | 0 | -1 | 1 | 0 |
| 31 May 16 | 0 | -1 | 1 | 0 |
| 29 Feb 16 | 0 | -1 | 1 | 0 |
| 30 Nov 15 | 0 | -1 | 1 | 0 |
| 31 Aug 15 | 0 | -1 | 0 | 0 |
| 31 May 15 | 0 | -1 | 0 | 0 |
質の高い収益: J is currently unprofitable.
利益率の向上: J is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: J is unprofitable, and losses have increased over the past 5 years at a rate of 19.3% per year.
成長の加速: Unable to compare J's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: J is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (39.8%).
株主資本利益率
高いROE: J has a negative Return on Equity (-20.54%), as it is currently unprofitable.